Navigation Links
Newly Published Study Showed Axiron® (testosterone) Topical Solution Restored Testosterone Levels to Normal Range in Hypogonadal Men
Date:6/28/2011

INDIANAPOLIS, June 28, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced that a pivotal Phase III Axiron study, published on the Clinical Endocrinology website, showed that Axiron® (testosterone) topical solution CIII, when applied to the underarm, met the primary study objective to restore testosterone levels to the normal range (300 – 1050 ng/dL) in men with low testosterone. In addition, secondary outcomes showed that the treatment of Axiron improved symptoms associated with low testosterone.

Testosterone deficiency, also known as hypogonadism or low testosterone, is a clinical condition in which the testicles, hypothalamus or pituitary gland is affected by disease or damage that results in inhibiting hormone secretion and testosterone production.(i)

About the Study

The Phase III open label, 120-day clinical study, conducted in 26 centers throughout the world, assessed the safety, pharmacokinetics and efficacy of a 2% formulation of testosterone topical solution (Axiron) applied daily to the underarm.  All 155 men began the study on a 60 mg dose and had their dose adjusted on Days 45 and 90, if necessary, to maintain their testosterone levels within the physiological range based on an average serum testosterone levels tested on Days 15 and 60, respectively.  On Day 120, of the 138 men for which there was evaluable data, 84% had an average testosterone concentration within the normal range (300-1050 ng/dL).  On Day 120, the majority of the men, 97 subjects, remained on 60 mg starting dose; three men were on 30 mg; 25 men were on 90 mg; and 10 men were on 120 mg.

The study also assessed the effect of treatment on symptoms associated with low testosterone as measured by the Psychosexual Daily Questionnaire.  Improvement in sexual desire and activity were apparent as early as 15 days (1.9 and 0.93 point
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. The Newly Combined Axcan and Eurand Announce Name Change to Aptalis
2. Global Pharm Holdings Group Obtains Business License for its Newly Established Joint-Venture in Jinan City
3. MedVantx and Blue Cross & Blue Shield of Rhode Island Partner to Provide Physicians with Integrated Medication Management Platform in Newly Created Patient-Centered Medical Homes
4. WaferGen Announces Data Presentations From Newly Launched High-Throughput SmartChip Human microRNA Panel V2 at Scientific Conferences, Including AACR
5. Breakaway From Cancer® Launches Newly-Enhanced Website Offering Comprehensive, Tailored Support for Cancer Patients
6. Zimmer Showcases Newly Acquired Line of Surgical Power Tools at 2011 AAOS Annual Meeting
7. Caldolor® Rapid Infusion Shown to be Safe and Well Tolerated in Newly Published Clinical Study
8. Newly Published Data Demonstrates Caldolor® Significantly Reduces Pain and Morphine Use in Post-Operative Patients
9. Apollo Endosurgery Demonstrates Clinical Functionality of the Newly Launched OverStitch™ Endoscopic Suturing System in Bariatric Repairs and GI Therapy
10. Capital BlueCross Newly Designed Health Care Reform Web Portal Features New Videos, Interactive Tool
11. Phase III Data Published in Lancet Show Novartis Drug Zometa® Improves Overall Survival in Newly Diagnosed Multiple Myeloma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is ... Advaxis, Inc. ("Advaxis" or the "Company") (NASDAQ: ... fiduciary duties to shareholders. On January 21, ... reporting that Advaxis had misrepresented the clinical data for ...
(Date:1/23/2015)... 2015  HyGreen, Inc., a leader in hand hygiene monitoring, ... Medical, a subsidiary of Ascendis Health Limited, in ... year, hundreds of millions of patients around the world ... transmitted from patient to patient via the unwashed hands ...
(Date:1/23/2015)... Inc. (ICBU) has repositioned itself as a holding company with ... in the hydroponic, hemp and medical marijuana sectors. By acquiring ... sector, and recently partnering with the Chippewa Tribe Nation to ... iMD is committing to bring its vision to the market ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2HyGreen Partners with RCA Medical in Johannesburg, South Africa 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2
... today announced that data,presented recently at the 17th ... demonstrate that the Genous Bio-engineered R,stent has better ... by Federico Piscione, M.D., the study,s principal,investigator and ... Naples,s,Division of Cardiology, Department of Clinical Medicine and ...
... in the Body, SEATTLE, July 7 Not ... antioxidant powers in the body: kiwifruit is among the,highest ... a recent small-scale study published in the Journal of ... phytochemicals called flavonoids that,may have the power to neutralize ...
Cached Medicine Technology:Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 2Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 3Kiwifruit: Antioxidant Power in Quantity and Quality 2
(Date:1/22/2015)... 2015 The Incredible Bulk is a revolutionary ... increase lean muscle by up to 30lbs in less than ... of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative review. , “Our ... step-by-step, scientific diet formula that allows the body to pack ...
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, has recently ... View website of AngelWeddingDress.com to find more details. ... online for a bridal party. AngelWeddingDress offers a variety ... Its maternity wedding dresses are specially designed for 2015. ...
(Date:1/22/2015)... 2015 A new white paper by ... person-centeredness in the long-term care environment as well as ... continuum. The paper, “The Power of Person-Centeredness in Long-Term ... practices of the patient, resident and family experience in ...
(Date:1/22/2015)... January 22, 2015 For over 20 years, Dr. ... Oceanside and Vista area has treated just about every type ... injury circumstances. And for those same twenty-plus years, the team ... all those injuries with the best possible doctor. With ...
(Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 ... College of Sports Medicine flagship journal Medicine & ... with L-Citrulline before exercise may help reduce gastrointestinal ... exercise. 1 , Participants in the double-blind, ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
... Drug-resistant bacterial infections are a growing concern, and much ... antibiotics to fight them. , Stanford researchers may have ... molecules very similar to natural proteins that play an ... could be an entirely new class of antibiotic drugs, ...
... disease treatments , , FRIDAY, March 7 (HealthDay News) ... types of blood cells, originate and are nurtured in ... may help researchers replicate the specific embryonic microenvironment necessary ... doctors can treat patients with diseases such as leukemia ...
... Capital Investments,Inc. (Amex: MGT ), a holding ... today commented on the American Cancer,Society,s (ACS) decision ... cancer screening guidelines. MGT Capital Investment,s,Medicsight PLC subsidiary, ... is an industry leader in the development of ...
... GXDX ), a specialized laboratory services provider, today ... Global,Health Care Conference at the Loews Miami Beach Hotel ... Dr. Tina Nova Bennett, President and CEO of Genoptix, ... Tuesday, March 18, 2008,beginning at approximately 10:45am EDT. They ...
... received a $30 million grant from the Bill & Melinda ... in pregnancy in Africa, Asia and Latin America. The ... who face exposure to malaria whilst pregnant every year. , ... partner institutions in 27 countries around the world. The ...
... only be needed a few times a year , , THURSDAY, ... angiotensin II receptors, thus relaxing blood vessels to lower blood ... new study suggests. , The advantage of the vaccine ... or three times a year and should help patients adhere ...
Cached Medicine News:Health News:Synthetic peptoids hold forth promise for new antibiotics 2Health News:Blood Stem Cells Originate in the Placenta 2Health News:MGT Comments on American Cancer Society's Decision to Endorse CT Colonography 2Health News:MGT Comments on American Cancer Society's Decision to Endorse CT Colonography 3Health News:MGT Comments on American Cancer Society's Decision to Endorse CT Colonography 4Health News:Genoptix Announces Participation at Lehman Brothers 11th Annual Global Health Care Conference 2Health News:LSTM to lead $30 million research program into malaria in pregnancy 2Health News:Vaccine Could One Day Control High Blood Pressure 2Health News:Vaccine Could One Day Control High Blood Pressure 3
... has the highest g-force ever. But optimal ... force. Optima MAX combines maximum force, capacity, ... performance that's worlds apart from any other ... and enhanced efficiency, Optima takes productivity to ...
... versatility, and environmental safety are ... LE-80 K Ultracentrifuge from Beckman ... Optima centrifugation technology, the LE-80 ... effectively provide advanced capability for ...
... Capable of generating 694,000 ... to 90,000 rpm, Beckman Coulter's ... to perform more separations in ... model operates with a broad ...
... L-XP ultracentrifuge is designed to play ... process if research involves proteomics, cytomics ... on-board computer, enhanced firmware, powerful Optima ... screen, Optima L-XP delivers superior functionality, ...
Medicine Products: